International Stem Cell (ISCO) Enterprise Value (2010 - 2026)

International Stem Cell (ISCO) has reported Enterprise Value for 17 consecutive years, with $431833.9 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 19.72% year-over-year to $431833.9 in Q2 2026; TTM through Jun 2026 was $431833.9, a 19.72% increase from a year earlier, with the FY2025 full-year figure at $127614.5, up 121.64% from the prior year.
• Enterprise Value was $431833.9 for Q2 2026 at International Stem Cell, up from $127614.5 in the prior quarter.
• Over five years, Enterprise Value peaked at $3.4 million in Q1 2022 and troughed at -$1.1 million in Q4 2023.
• A 5-year average of $317943.2 and a median of $74570.5 in 2025 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value tumbled 258.52% in 2023 and surged 144.55% in 2025, its largest moves.
• Over 5 years, Enterprise Value stood at $698790.1 in 2022, then plunged by 258.52% to -$1.1 million in 2023, then surged by 46.77% to -$589648.9 in 2024, then jumped by 121.64% to $127614.5 in 2025, then soared by 238.39% to $431833.9 in 2026.
• The last three Enterprise Value figures came in at $431833.9 (Q2 2026), $127614.5 (Q4 2025), and $74570.5 (Q3 2025), per Business Quant data.